To Evaluate the Effect of AZD3199 on the Electrical Activity in the Heart

NCT01222442 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease
Lung Disease

Interventions

DRUG: AZD3199
DRUG: Moxifloxacin
OTHER: Placebo comparator

Sponsor

AstraZeneca